If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
TREATMENT STRATEGIES
HEPATOLOGY
Volume 3 Issue 1
• Congress Review
• Hepatic Encephalopathy
• Hepatocellular Carcinoma
• Liver Disease
Includes a Review of the 51st Annual
Meeting of the EASL - ILC 2016
Robust protection against
recurrent episodes of hepatic
encephalopathy (HE)1
2-YEAR
DATA
6-month data
Daily treatment with XIFAXAN® 550* b.d. plus lactulose significantly reduced episodes† and
hospitalisations‡ compared with placebo plus lactulose1, and improved quality of life2 in
patients with HE.
2-year data
The reduction in hospitalisations compared to placebo plus lactulose observed over 6 months
is maintained over 2 years in patients treated with XIFAXAN® 550 b.d. plus lactulose.1,3 The
2-year infection rates are lower than those observed in patients treated with XIFAXAN® 550
b.d. plus lactulose for 6 months, and
TREATMENT STRATEGIES HEPATOLOGY Volume 3 Issue 1
Robust protection against recurrent episodes of h
TREATMENT HEPATOLOGY STRATEGIES - TREATMENT ST
CHRONIC LIVER DISEASEA SLOW, SILENT, BUT PREVENTA
CONTENTS... 03 08 11 12 14 1
GLOBAL STAFFING SOLUTIONS Cont
35 43 49 55
TREATMENT STRATEGIES - HEPATOLOGY Editorial Advis
MONDAY 02 JUNE 2014 NORGINE ADVERT
For the latest hepatitis treatment news and infor
Treatment Strategies - Congress Review The Inte
Treatment Strategies - Congress Review The Host C
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review New Resea
Treatment Strategies - Congress Review 2016 I
Treatment Strategies - Congress Review Community-
Treatment Strategies - Congress Review Fou
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review Algorithm
Treatment Strategies - Congress Review Coffee Con
Treatment Strategies - Congress Review Breast
Treatment Strategies - Congress Review Capsid Ass
Treatment Strategies - Congress Review Waist Over
Treatment Strategies - Congress Review Treatment
Treatment Strategies - Congress Review Treatment
Treatment Strategies - Congress Review Genotype 3
Treatment Strategies - Congress Review High Rat
Treatment Strategies - Congress Review Curren
Treatment Strategies - Congress Review Scoring
Treatment Strategies - Congress Review Livers Inf
Treatment Strategies - Congress Review Long-
Treatment Strategies - Congress Review ILC 2017..
Treatment Strategies - Congress Review terrace is
Treatment Strategies - Congress Review The Inter
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
In parallel with these findings, oedema was not i
Treatment Strategies - Hepatic Encephalopathy
Following treatment, there were no further hospit
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy V
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
Treatment Strategies - Hepatocellular Carcinoma
C CAMBRIDGE RESEARCH CENTR
Treatment Strategies - Liver Disease MANIFE
Treatment Strategies - Liver Disease and macro
Treatment Strategies - Liver Disease
Treatment Strategies - Liver Disease 129Sv mic
Treatment Strategies - Liver Disease
Treatment Strategies - Liver Disease References
nonalcoholic steatohepatitis: role of short-form
Treatment Strategies - ILC 2017 The Internationa
Treatment Strategies - Buyer's Guide Buye
The Cambridge Research Centre The Cambridge